Compare
Pit 2–4 stocks against each other: U-Score, pillars, fundamentals, and normalized price history. Same universe, same methodology, one view.
| Metric | ALKEM Alkem Laboratories Limited Pharma · Mid | GLENMARK Glenmark Pharmaceuticals Limited Pharma · Mid | APLLTD Alembic Pharmaceuticals Limited Pharma · Mid | LUPIN Lupin Limited Pharma · Mid |
|---|---|---|---|---|
| Final Score | 51 | 65 | 35 | 79 |
| Verdict | FAIR VALUE | UNDERVALUED | WATCHLIST | DEEP VALUE |
| Style | Financial Turnaround | Premium Compounder | WATCHLIST | Top Setup |
| Piotroski | 8/9 | 8/9 | 8/9 | 8/9 |
| Valuation | 4/30 | 1/30 | 6/30 | 14/30 |
| Growth | 13/25 | 23/25 | 4/25 | 25/25 |
| Quality | 13/20 | 20/20 | 2/20 | 20/20 |
| Balance Sheet | 10/15 | 10/15 | 13/15 | 9/15 |
| Cash Flow | 6/10 | 6/10 | 5/10 | 6/10 |
| Price | ₹5,322.5 | ₹2,209.6 | ₹731.5 | ₹2,263 |
| P/E | 26.30 | 20.80 | 20.10 | 17.90 |
| P/B | 4.63 | 5.85 | 2.58 | 4.59 |
| ROE | 18.90% | 30.50% | 13.40% | 29.10% |
| ROCE | 21.20% | 39.80% | 12.60% | 30.30% |
| Debt / Equity | 0.10 | 0.06 | 0.25 | 0.29 |
| FCF Yield | 2.81% | 3.52% | 1.89% | 3.37% |
| Dividend Y | 0.84% | 0.11% | 1.48% | 0.53% |
| Altman Z | 7.79 | 6.46 | 5.24 | 6.40 |
| Promoter % | 51.20% | 46.65% | 69.74% | 46.85% |
| Mkt Cap (₹Cr) | 64048.00 | 61421.00 | 14654.00 | 103065.00 |
| Graham # | ₹2,237.67 | ₹635.56 | ₹472.47 | ₹1,135.21 |
| Fair PE | 30.3 | 42.0 | 4.2 | 42.0 |
| MoS % | +8.7% | -9.0% | -406.2% | +53.8% |
Normalized price (3-year, indexed to 100)
Higher line = better relative performance from startALKEM94
GLENMARK133
APLLTD70
LUPIN108